WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Stock

Open Broker Account
$0.83-0.08 (-8.79%)
Updated Sep 23, 2022
VVOS Price
$0.83
Fair Value Price
$1.67
Market Cap
$19.05M
52 Week Low
$0.72
52 Week High
$4.72
P/E
-0.79x
P/B
0.91x
P/S
3.37x
PEG
N/A
Dividend Yield
N/A
Revenue
$16.90M
Earnings
-$22.40M
Gross Margin
72.7%
Operating Margin
-132.51%
Profit Margin
-132.6%
Debt to Equity
0.42
Operating Cash Flow
-$18M
Beta
1.25
Next Earnings
Nov 14, 2022
Ex-Dividend
N/A
Next Dividend
N/A

VVOS Overview

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VVOS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VVOS ($0.83) is undervalued by 50.34% relative to our estimate of its Fair Value price of $1.67 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
VVOS ($0.83) is significantly undervalued by 50.34% relative to our estimate of its Fair Value price of $1.67 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
VVOS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VVOS due diligence checks available for Premium users.

Be the first to know about important VVOS news, forecast changes, insider trades & much more!

VVOS News

Valuation

VVOS fair value

Fair Value of VVOS stock based on Discounted Cash Flow (DCF)
Price
$0.83
Fair Value
$1.67
Undervalued by
50.22%
VVOS ($0.83) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VVOS ($0.83) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VVOS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VVOS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.79x
Industry
28.92x
Market
27.65x

VVOS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.91x
Industry
3.53x
VVOS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VVOS's financial health

Profit margin

Revenue
$3.5M
Net Income
-$5.5M
Profit Margin
-159.4%
VVOS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VVOS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$29.6M
Liabilities
$8.7M
Debt to equity
0.42
VVOS's short-term assets ($21.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VVOS's short-term assets ($21.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VVOS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.1M
Investing
-$120.0k
Financing
$0.0
VVOS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VVOS vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
VVOS$19.05M-9.01%-0.79x0.91x
PETV$19.17M-4.02%-2.77x4.51x
NVCN$18.06M-0.83%-0.55x0.51x
BIOL$17.75M-4.78%-0.87x0.82x
TNON$17.64M-4.27%N/A1.17x

Vivos Therapeutics Stock FAQ

What is Vivos Therapeutics's quote symbol?

NASDAQ: VVOS) Vivos Therapeutics trades on the NASDAQ under the ticker symbol VVOS. Vivos Therapeutics stock quotes can also be displayed as NASDAQ: VVOS.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.

What is the 52 week high and low for Vivos Therapeutics (NASDAQ: VVOS)?

(NASDAQ: VVOS) Vivos Therapeutics's 52-week high was $4.72, and its 52-week low was $0.72. It is currently -82.46% from its 52-week high and 15% from its 52-week low.

How much is Vivos Therapeutics stock worth today?

(NASDAQ: VVOS) Vivos Therapeutics currently has 23,012,119 outstanding shares. With Vivos Therapeutics stock trading at $0.83 per share, the total value of Vivos Therapeutics stock (market capitalization) is $19.05M.

Vivos Therapeutics stock was originally listed at a price of $7.79 in Dec 14, 2020. If you had invested in Vivos Therapeutics stock at $7.79, your return over the last 1 years would have been -89.37%, for an annualized return of -89.37% (not including any dividends or dividend reinvestments).

How much is Vivos Therapeutics's stock price per share?

(NASDAQ: VVOS) Vivos Therapeutics stock price per share is $0.83 today (as of Sep 23, 2022).

What is Vivos Therapeutics's Market Cap?

(NASDAQ: VVOS) Vivos Therapeutics's market cap is $19.05M, as of Sep 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vivos Therapeutics's market cap is calculated by multiplying VVOS's current stock price of $0.83 by VVOS's total outstanding shares of 23,012,119.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.